pretty simple, the phase I tests had impressive results, people with this kind of brain cancer are living longer, beating the base, control group significantly because of the treatment from IMUC, Professionals in oncology recognize this breakthrough and are buying a lot of this.
As I said this morning since we traded at $4 off enrollement and market upgrade I would expect that we see a retest of that. The move up will be swift and then I expect to see trading between $3.50 and $4.00 until some sort of news..of course "that" news will either move the stock to $20+ or to less than $1.00. I won't say what stock but in 1991 I bought a bio stock at 52 week low ($5.50) and sold it 2 days later for $27.50. The right news on IMUC could blow it up..or down..thats the way it go. GLTA